We partner with the media to inform the public of the global human crisis.
July 21, 2021Indivior to Announce Q2/H1 2021 Results and Host a Presentation on July 29th...
June 30, 2021Indivior Raises FY 2021 Guidance...
June 24, 2021Indivior Presents New Data at the College on Problems of Drug Dependence (CPDD) 2021 Annual Conference...
June 8, 2021Indivior Extends Leadership Position in Substance Use Disorder Treatment with Exclusive Agreement for Leading Asset Targeting Cannabis-Related Disorders....
April 30, 2021Indivior Applauds Biden Administration’s New Buprenorphine Practice Guidelines...
The information provided below is provisional and subject to change. Details of each event, including venue information, will be confirmed shortly before they are due to take place.
June 1, 2021
July 29, 2021
Global Media Contacts
EMEA, Australasia and China Financial Disclosure Reporting
Disclosure Of Payments, Donations & Joint Working
The Online Press Kit is designed to help media research our company for background information or follow-up stories. Please visit the links below to learn more.
About Indivior PLC – An overview of Indivior, including our worldwide locations and key products
Board of Directors – Biographies of Indivior’s Board
The Indivior PLC Pipeline – Information about the Indivior R&D efforts and progress of medicines in the pipeline